Insider Stock Trading History of Holmes Scott A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Holmes Scott A since year 2005. The trader's CIK number is 1537670. At the time of this reporting, Holmes Scott A is the Chief Financial Officer of Keryx Biopharmaceuticals Inc . (stock ticker symbol KERX). See this page for all insider trading activities at Keryx Biopharmaceuticals Inc .

Note that in the past Holmes Scott A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Holmes Scott A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-30 KERX Keryx Biopharmaceuticals Inc Sale 2,582 6.03 15,569
2017-07-31 KERX Keryx Biopharmaceuticals Inc Sale 1,445 7.14 10,317
2017-07-28 KERX Keryx Biopharmaceuticals Inc Sale 1,236 6.96 8,602
2017-05-01 KERX Keryx Biopharmaceuticals Inc Sale 1,441 5.97 8,602
2017-04-28 KERX Keryx Biopharmaceuticals Inc Sale 1,219 5.89 7,179
2017-01-30 KERX Keryx Biopharmaceuticals Inc Sale 8,447 4.65 39,278
2016-10-28 KERX Keryx Biopharmaceuticals Inc Sale 1,237 4.44 5,492
2016-07-29 KERX Keryx Biopharmaceuticals Inc Sale 4,935 7.36 36,321
2015-11-03 KERX Keryx Biopharmaceuticals Inc Buy 3,672 5.30 19,457
2015-11-04 KERX Keryx Biopharmaceuticals Inc Buy 1,328 5.40 7,171
2015-08-21 KERX Keryx Biopharmaceuticals Inc Buy 5,000 5.72 28,590
2015-07-31 KERX Keryx Biopharmaceuticals Inc Sale 2,758 7.87 21,705
2015-06-15 AMAG Advanced Magnetics Inc Option Ex 6,234 15.72 97,998
2015-06-15 AMAG Advanced Magnetics Inc Sale 7,580 66.63 505,055
2015-06-03 AMAG Advanced Magnetics Inc Sale 22,516 68.88 1,550,902
2012-12-05 AMAG Advanced Magnetics Inc Option Ex 2,500 .00 0
2012-12-05 AMAG Advanced Magnetics Inc Sale 2,500 14.79 36,975
2012-09-12 AMAG Advanced Magnetics Inc Sale 750 15.54 11,655

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Holmes Scott A (Chief Financial Officer of Keryx Biopharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.